Skip to main content

Advertisement

Log in

5-Hydroxytryptamine in a Carcinoid Tumour

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

ERSPAMER1 was the first to assume enterochromaffine cells of the gastrointestinal tract to contain enteramine (5-hydroxytryptamine serotonin). Feyrter2 regarded these cells as a part of the entity he calls the “Helle-Zellen-Systeme” in general, subdividing it into the “Insuläres Gangorgan” of the pancreas, the probable origin of glucagon (Gaede, Ferner and Kastrup3), and the “Gelbe-Zellen” or enterochromaffine cells of the gastrointestinal tract. Carcinoids, which are tumours originating from these cells, have already been examined with regard to pharmacodynamically active substances by Feyrter and Unna4 and by Selberg5. Their results were inconclusive and divergent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Erspamer, V., Arch. Exp. Path. Pharmakol., 218, 92 (1953).

    Article  CAS  Google Scholar 

  2. Feyrter, F., “Über die peripheren endokrinen Drüsen des Menschen” (Maudrich, Vienna and Düsseldorf, 1953).

    Google Scholar 

  3. Gaede, K., Ferner, H., and Kastrup, H., Klin. Wochenschr., 388 (1951).

  4. Feyrter, F., and Unna, K., Virchow's Arch., 298, 187 (1936).

    Article  Google Scholar 

  5. Selberg, W., Klin. Wochenschr., 1271 (1941).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LEMBECK, F. 5-Hydroxytryptamine in a Carcinoid Tumour. Nature 172, 910–911 (1953). https://doi.org/10.1038/172910a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/172910a0

  • Springer Nature Limited

This article is cited by

Navigation